Proton pump inhibitors (PPI) vs control
Number of participants with worsening scores in corporal atrophy · people with pre‐malignant lesions
Proton pump inhibitor showed no clear difference in number of participants with worsening scores in corporal atrophy compared with control (low certainty).
1 finding from 1 review
- Long‐term proton pump inhibitor (PPI) use and the development of gastric pre‐malignant lesions 2014 · Cochrane Headline outcomes onlyOR 1.5 [0.59, 3.8]4 studies · 1070 participantsLow